ANN MARIE RUSTIA

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family BALTIMORE, MD NPI 1992039622

General Payments — all program years on this page

$4,404.72

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 229
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $822.61 across 40 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $822.6140

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $1,038.3565
2022 $1,167.4160
2023 $1,376.3564
2024 $822.6140

Records — PY2024 (40)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086361328 Bayer Healthcare Pharmaceuticals Inc. $19.97 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087306149 Novartis Pharmaceuticals Corporation $19.29 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100352116 Novo Nordisk Inc $15.19 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100398968 Novo Nordisk Inc $21.84 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100418027 Novo Nordisk Inc $19.79 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100493503 Novo Nordisk Inc $15.42 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100592378 Novo Nordisk Inc $17.39 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100628756 Novo Nordisk Inc $20.80 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100651197 Novo Nordisk Inc $14.30 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101568506 E.R. Squibb & Sons, L.L.C. $24.30 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104199469 AstraZeneca Pharmaceuticals LP $25.11 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104335236 AstraZeneca Pharmaceuticals LP $24.96 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104698240 AstraZeneca Pharmaceuticals LP $26.35 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105265430 AstraZeneca Pharmaceuticals LP $21.33 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105468991 AstraZeneca Pharmaceuticals LP $14.12 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105600731 AstraZeneca Pharmaceuticals LP $26.57 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105620057 AstraZeneca Pharmaceuticals LP $23.57 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105807260 AstraZeneca Pharmaceuticals LP $26.11 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108128236 ABBVIE INC. $21.42 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108128238 ABBVIE INC. $27.93 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108128240 ABBVIE INC. $21.31 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116075184 Amgen Inc. $14.02 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116197525 GlaxoSmithKline, LLC. $20.64 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116456935 GlaxoSmithKline, LLC. $22.42 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116538496 GlaxoSmithKline, LLC. $24.93 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117671997 Amgen Inc. $15.08 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117671999 Amgen Inc. $15.18 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117774971 Corcept Therapeutics $15.13 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118263287 Boehringer Ingelheim Pharmaceuticals, Inc. $16.76 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118263289 Boehringer Ingelheim Pharmaceuticals, Inc. $24.64 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118263291 Boehringer Ingelheim Pharmaceuticals, Inc. $25.85 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129475518 Esperion Therapeutics, Inc. $16.85 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129475520 Esperion Therapeutics, Inc. $14.18 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131339003 PFIZER INC. $15.05 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131743026 PFIZER INC. $20.09 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135513640 Lilly USA, LLC $26.12 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135517246 Lilly USA, LLC $14.38 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139471752 Astellas Pharma US Inc $27.75 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153349228 Dexcom, Inc. $21.09 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153691584 Salix Pharmaceuticals, a division of Bausch Health US, LLC $25.38 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.